Trial Profile
PCIRN Evaluation of Pandemic H1N12009 Influenza Vaccine in Aboriginal Children and Adults.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Jul 2015
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- 12 Feb 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
- 12 Feb 2010 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 03 Nov 2009 New trial record